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Received February 26, 2014; accepted June 10, 2014AbstractHead and neck cancer is a critical global health problem and approximately 650,000 patients per year are diagnosed with this type of cancer.
In addition, head and neck cancer exhibits a high recurrence rate, readily causing second primary cancers in other locations, often yielding a poor
prognosis. Current medical and surgical treatment options result in considerable impairment of speaking and swallowing functions, with side
effects such as nausea, vomiting, bone marrow suppression, and renal damage, thereby impairing patients' quality of life. Thus, developing a
prevention and therapeutic intervention strategy for head and neck cancer is vital. Phytochemicals have been shown to have a unique ability to
protect cells from damage and modulation of cell repair. The chemopreventive activities of phytochemicals have also been demonstrated to be
associated with their antioxidant properties and the induction and stimulation of intercellular communication via gap junctions, which play a role
in the regulation of cancer cell cycle, differentiation, apoptosis, and stagnate cancer cell growth. Phytochemicals can also regulate cancer cell
signaling pathways, reduce the invasion and metastasis of cancer cells, and protect normal cells during treatment, thus reducing the damage
caused by chemotherapy and radiotherapy. The most studied of the chemopreventive effects of phytochemicals are the carotenoids and phe-
nolics. In this review, we investigated the multiple mechanisms of carotenoids and polyphenols (PPs) for use in preventing head and neck cancer,
reducing the side effects of chemotherapy and radiotherapy, improving patient survival rates, and reducing the occurrence rate of second primary
cancers.
Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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1726-4901/Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Assthan 90% of these cancers are head and neck squamous cell
carcinomas (HNSCCs).1 People diagnosed with this type of
cancer account for approximately 6% of the cancer population.
Every year, approximately 650,000 people are diagnosed with
head and neck cancer, and 320,000 people die of the disease.2
Statistics released by the Health Promotion Administration
(HPA) showed that the numbers of Taiwanese people diag-
nosed with oral or esophageal cancer are the highest among
member countries of the Organization for Economic Cooper-
ation and Development. In the Top Ten Deadly Cancers list
published by the Ministry of Health and Welfare in 2012, oral
cancer was ranked fifth. The recurrence rate is high in patientsociation. All rights reserved.
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likely to occur in locations such as the oral cavity, throat, and
esophagus. Studies conducted by the HPA indicated that the
risk of male patients with oral cancer developing a second
primary cancer was 3.8 times that of other people. Addition-
ally, the risk of patients with oral cancer (of both sexes) of
developing second primary cancer was 2.4 times that of the
risk of people with other types of cancer. The prognosis of
patients with oral and second primary cancers is often poor.
Thus, preventing and tracking the development of secondary
primary cancer is vital.
The treatments performed on patients with head and neck
cancer primarily involve surgical resection, radiotherapy,
chemotherapy, or a combination of these methods. The
medication used in chemotherapy is often cisplatin or fluoro-
uracil (5-FU). However, resistance occurs frequently during
treatment, and previously controlled cancer cells can rede-
velop. The toxicity of the medication may also result in side
effects such as nausea, vomiting, bone marrow suppression,
and renal damage, thereby impairing the quality of life of
patients. Radiotherapy involves using rapid photons to collide
with the basic atomic structure of organisms, causing the
electrons traveling on peripheral tracks to leave the tracks.
Consequently, oxidative stress occurs, generating large
amounts of reactive oxygen species (ROS), damaging the
DNA in cells. Thus, the cells lose their ability to divide and
proliferate.3 The side effects of radiotherapy primarily include
oral mucositis, dermatitis, xerostomia, dysphagia, osteonec-
rosis, trismus, and neck muscle fibrosis. These conditions
considerably jeopardize the quality of life of patients, thereby
decreasing patient willingness to receive treatment. The pri-
mary causes of head and neck cancer are unhealthy habits such
as betel nut chewing, smoking, and excessive drinking.4,5
Insufficient vegetable and fruit intake is another contributor
to oral cancer.6 Riboli and Norat7 analyzed numerous case-
econtrol studies and found that low vegetable and fruit intake
contributed to an increased risk of oral, pharyngeal, and
laryngeal cancer, as well as increasing the risk of recurrent
primary cancers (e.g., lung and esophageal cancers) in early-
stage head and neck cancer survivors.
First proposed in 1976 in the USA by National Cancer
Institute scholar Michael Sporn,8 cancer chemoprevention
involves using natural or synthetic substances to prevent,
block, suppress, or reverse cancer in the initiation, promotion,
and progression stages. Chemoprevention consists of Level 1
and Level 2 preventiondthat is, treating pathological changes
that occur prior to cancer, and preventing post-surgery recur-
rence and the occurrence of second primary cancer, respec-
tively. This strategy is vital in current cancer prevention and
treatment. The substances used to achieve chemoprevention
must be safe and the effective doses should be limited to
minimal levels to prevent significant toxicity. Additionally,
vegetables and fruits have the potential ability to prevent and
inhibit cancer9,10 primarily because these foods contain large
amounts of natural chemicals, called phytonutrients or phy-
tochemicals. As determinants of the color, aroma, and taste of
plants, phytochemicals are vital for plants to grow healthily.Phytochemicals are defined as bioactive nonnutrient plant
compounds in fruits, vegetables, grains, and other plant foods,
and can be classified as carotenoids, phenolics, alkaloids,
nitrogen-containing compounds, and organosulfur com-
pounds.11 Regarding the mechanism of the effects that phy-
tochemicals have on the human body, Liu12 argued that
phytochemicals can reduce the risks of cardiovascular diseases
and cancer possibly because of their antioxidant activity.
Lampe13 indicated that phytochemicals regulate detoxifying
enzymes and the immune system, possibly by altering the
metabolism of cholesterols and steroid hormones. Phyto-
chemicals can be used to develop novel chemoprevention and
chemotherapy methods and function as assistive alternatives
for conventional treatments. Although there are no recom-
mended dietary allowances for phytochemicals, higher doses
increase the risk of toxicity. Therefore, it is not recommended
to take megadoses of purified phytochemicals as dietary sup-
plements before strong supporting scientific evidence confirms
its safety.11 In this review, we primarily focus on exploring the
protective effects and mechanisms of carotenoids and poly-
phenols (PPs) on patients with head and neck cancer.
2. The prevention and treatment effects of phytonutrients
on patients with head and neck cancer2.1. CarotenoidsCarotenoids are fat-soluble pigments; >700 types of ca-
rotenoids have been extracted and identified. However, only 24
of these carotenoids have been found in human blood and
tissues, and two of them exist in the retina and lens of the
human eye. The most extensively researched carotenoids
include b-carotene, lycopene, lutein, and zeaxanthin. The
carotenoid concentration in blood is an effective indicator of
dietary intake. Carughi and Hooper14 found that healthy
people who have been on a 2-week low-carotenoid diet
(<0.4 mg/d) exhibited blood carotenoid levels that were <60%
of the initial levels observed at the beginning of the experi-
ment. After the participants consumed carotenoid-rich vege-
tables and fruits for 1 week, the carotenoids in the blood
increased to the original value. The human body can absorb
large amounts of carotenoids from natural foods (e.g., vege-
tables and fruits). Specifically, b-carotene, a-carotene, and b-
cryptoxanthin in the human body have vitamin A activity,
which means that these carotenoids can be converted to
retinol. Additionally, carotenoids are superior antioxidants,
capable of capturing singlet oxygen and participating in
restoring gap junction intercellular communication (GJIC).
GJIC abnormalities are significantly related to cancer cell
generation.15 Studies have shown that the levels of b-carotene,
lycopene, and vitamin E observed in the blood plasma of
patients with HNSCC16,17 and oral leukoplakia18 were lower
than those of healthy people. Sakhi et al19 indicated that the
levels of lutein, zeaxanthin, a-carotene, b-carotene, lycopene,
and total carotenoids observed in the blood of patients with
HNSCC were lower than those of healthy people. Because
patients with HNSCC consume smaller amounts of vegetables
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the blood plasma of these patients are relatively low; conse-
quently, the risk of developing oral, pharyngeal, and laryngeal
cancer increases.6 Previous studies have also shown that
relatively high plasma levels of glutathione20 and carotenoid21
were observed after radiotherapy in HNSCC patients that can
increase the survival rates of these patients. Sakhi et al21
observed that compared with healthy people, patients first
diagnosed with HNSCC exhibited significantly higher oxida-
tive stress prior to receiving radiotherapy. The total hydro-
peroxide (derivatives of reactive oxygen metabolites, d-
ROMs) level in blood, an indicator of oxidative stress, is
relatively high. Subsequently, the side effects resulting from
radiotherapy affect eating; consequently, vegetable and fruit
intake decreases, which lessens antioxidant intake. Addition-
ally, the free radicals resulting from the radiation necessitate
increased antioxidant usage. Therefore, the antioxidant levels
in patients' blood decreases. Because of the location of tumors
and the side effects of radiotherapy, the average b-carotene
dietary intake of HNSCC patients is 50% less than that of
healthy people.19
Meyer et al22 studied 540 HNSCC patients and found that
when patients' average dietary intake of b-carotene was low
during radiotherapy, the risks of severe side effects and local
recurrence increased. The dietary intake of b-carotene and
high-dose b-carotene supplements are both effective in
reducing the frequency and severity of radiotherapy-induced
side effects. In other words, b-carotene can protect normal
tissues from radiation injury. However, b-carotene supplements
increased cancer recurrence rates, possibly because the anti-
oxidant capacity of b-carotene supplements also protects tumor
cells from radiation injury, thereby jeopardizing the effect of
radiotherapy. By contrast, the b-carotene derived from dietary
intake poses no such problem. Sakhi et al19 observed that
HNSCC patients after receiving radiation therapy exhibited
three to four times lower carotenoid levels than a healthy
control group. A longitudinal study of the survival rates of theFig. 1. The categories, chemical structures, and reHNSCC patients indicated that the postradiation carotenoid
(i.e., lutein, a-carotene, and b-carotene) levels in blood were
positively correlated with progression-free survival (PFS).
Regarding recommended carotenoid intake, Le Marchand
et al23 examined HNSCC patients and patients with lung
squamous cell carcinoma and found that increasing their daily
vegetable and fruit intake from four to eight servings and
maintaining this regimen for 3 months resulted in significantly
increased carotenoid levels in the blood and improved survival
rates. In summary, blood carotenoid level can be used as a
reference indicator of vegetable and fruit intake. Increasing
vegetable and fruit intake can prevent the development of
HNSCC and reduce the frequency and severity of
radiotherapy-induced side effects and local recurrence rates
for HNSCC patients while increasing PFS.2.2. PPsPPs constitute the largest group of phytochemicals. More
than 8000 PPs have been identified, which can be divided into
the following structural categories: phenolic acids, flavonoids,
lignans, and stilbenes. Specifically, phenolic acids and flavo-
noids account for 30% and 60% of the known PPs, respec-
tively. Fig. 1 shows the categories, chemical structures, and
representative compounds of PPs.
Additionally, PPs have antioxidant capacity. The phenolic
groups can accept an electron to form relatively stable phe-
noxyl radicals, thereby ending chain oxidation and thus pro-
tecting cells from oxidative damage. Consequently, the risks of
degenerative diseases associated with oxidative stress can be
reduced. Studies have shown that within hours of consuming
vegetables, fruits, and drinks (e.g., tea or red wine) rich in PPs,
the body exhibits significantly increased antioxidant capac-
ity.24,25 Duthie et al26 argued that PPs can alter gene expres-
sion, increase apoptosis, upregulate gap junction
communication, activate P-glycoproteins, and regulate the
activity of enzymes related to carcinogen activity andpresentative compounds of polyphenols (PPs).
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the initiation, promotion, and progression of tumor cells,
exhibiting anticancer properties. Additionally, PPs can prevent
oral cancer, possibly because PPs come in contact with tissues
directly before being absorbed and metabolized,28 and the
biologically active ingredients inhibit the proliferation of oral
cancer cells in the surface of epithelial cells.29
The PP content of food is affected by factors such as the
variety, ripeness, and storage of food. Therefore, no compre-
hensive reference table for food ingredients is available.
Ovaskainen et al30 assessed the diet records of Finnish adults
and identified an average daily PP intake of approximately
863 mg, of which 75% was phenolic acids, 14% was proan-
thocyanidins, and 10% was anthocyanins and other flavonoids.
However, little is known regarding the absorption, bioavail-
ability, biodistribution, and metabolism of PPs. Free aglycones
allow intestinal absorption, whereas the majority of PPs exist
in food in the form of esters, glycosides, and polymers. These
PPs can only be absorbed after hydrolysis by intestinal en-
zymes or colonic microflora. Microorganisms in the oral
cavity and intestines can decompose PPs to aglycones or oc-
casionally to form aromatic acids. The metabolic detoxifica-
tion process causes the absorbed PPs to bind and form
methylation, glucuronidation, and sulfation derivatives.31
Consequently, aglycones cannot be detected or only a low
level of aglycones can be detected in the blood after PPs are
absorbed. PPs can be observed in numerous tissues, primarily
in the mucous membrane of the digestive tract. The highest PP
level is observed in the oral mucosa.32 The most easily
absorbed PPs are isoflavones and gallic acid, followed by
flavanones, catechins, and quercetin glycosides, and the least
easily absorbed are proanthocyanidins, anthocyanins, and
galloylated catechins. However, all PPs are primarily dis-
charged through urine and bile.29,31,33e35 Several studies have
indicated that PPs have anti-HNSCC activity, including but not
limited to catechins and proanthocyanidins.
2.2.1. Green tea polyphenols
Green tea polyphenols (GTPs) can be divided into four
main categories: epicatechin (EC), epigallocatechin (EGC),
epicatechin-3-gallate (ECG), and epigallocatechin-3-gallate
(EGCG). The effects of EGCG on the inhibition of cancer
cell generation have been extensively researched and have
received significant attention. Epidermal growth factor re-
ceptors (EGFRs) are a type of glycoprotein receptor and
perform various functions by activating the protein tyrosine
kinase in cells. Excessive EGFR expression is often observed
in patients with head and neck cancer. These receptors allow
cancer cells to grow, transfer, and develop resistance rapidly.
EGCG can inhibit the signaling pathways of EGFRs, thereby
inhibiting cancer development and progression. Amin et al36
found that the synergy between EGCG and EGFR blockers
can inhibit HNSCC growth. Amin et al36 also indicated that
the synergy between Erlotinib and EGCG inhibits HNSCC
growth by inhibiting the activity of nuclear factor-kb (NF-kb).
In an in vitro study, the effects of EGCG on the multiple-step
carcinogenesis of oral cancer were examined. The resultsshowed that EGCG can inhibit the growth of human oral
leukoplakia cell lines, MSK Leuk1, MSK Leuk1s, and 1483
HNSCC cell lines, as well as the phosphorylation of retino-
blastoma protein. Consequently, cell cycle arrest occurs in the
Growth 1 (G1) phase, and progression is inhibited.37 The
catechins in tea inhibit the activity of oral squamous cell
carcinoma (OSCC), thereby inhibiting the production of ma-
trix metalloproteinases (MMPs). Thus, the invasion and
migration of cancer cells can be controlled38 and cancer cell
apoptosis and growth arrest are induced.39 Yamamoto et al40
observed that drinking green tea causes the EGCG concen-
tration in saliva to reach 50 mM (i.e., the normal physiological
concentration), which ensures the protection of normal sali-
vary gland cells and the alleviation of damage caused by
chemotherapy medication such as g-irradiation and cis-
platinum (II) diammine dichloride (CDDP). However, EGCG
also protects oral cancer cells, thereby hindering the effects of
chemoradiotherapy. When EGCG concentration is high (e.g.,
200 mM), the cytotoxicity of CDDP to OSCC cell lines (OSC-
2 and OSC-4) can be increased. Shin et al41 demonstrated that
EC protected the human keratinocyte line (HaCaT) in vitro
from radiation by inhibiting ROS generation, maintaining the
mitochondrial integrity, and blocking mitogen-activated pro-
tein kinase (MAPK) activation. Moreover, EC is an effective
means of reducing oral mucositis and facilitates wound heal-
ing after radiation exposure in the oral cavity of rats. Pisters
et al42 used green tea extracts to treat late-stage cancer pa-
tients. The results of a Phase I clinical test showed that the
dose of the green tea extract (i.e., 1000 mg/m2) was within the
safe range. Seeram et al43 conducted a pilot study with
smokers and found that doses of 2000e2500 mg/day of green
tea extract can reduce the DNA damage caused by smoking
and increase apoptosis. Nevertheless, long-term studies that
use higher doses must be conducted to verify the benefits of
applying GTPs to prevent and treat head and neck cancer.
2.2.2. Proanthocyanidins
Proanthocyanidins are polyphenolic compounds that can be
found in fruits such as grapes, cranberries, and blueberries.
Also called condensed tannins, proanthocyanidins are formed
by monomeric flavan-3-ols. Based on the degree of polymer-
ization, they can be divided into monomeric, oligomeric, and
polymeric proanthocyanidins. Grapes are rich in proantho-
cyanidins, approximately 60e70% of which are stored in the
grape seeds. Grape seed proanthocyanidins (GSPs) form di-
mers, trimers, tetramers, and oligomers.44 Ye et al45 argued
that GSPs exert cytotoxicity on tumor cells but cause no side
effects on normal cells. The results of animal studies have
shown that GSPs can prevent tumor generation and have no
apparent toxicity on animals.46 A HNSCC study conducted by
Prasad and Katiyar47 indicated that GSPs significantly
decreased the viability of human HNSCC cells while inducing
apoptosis. In the same study, the scholars observed that GSPs
were not toxic to normal human bronchial epithelial cells and
that GSPs can inhibit the expression of cyclins (cyclin D1 and
cyclin D2) and cyclin-dependent kinases (Cdks) in HNSCC
cells. Thus, the cell cycle progression in these uncontrolled
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Cdkecyclin complexes by increasing the expression of Cdk
inhibitory (Cdki) proteins (Cip1/p21, Kip1/p27) and the
binding of Cdki and Cdks. Consequently, cell cycle arrest
occurs in the G1 phase48,49; thus, cells are “offered” the op-
tions of restoration or apoptosis. The same study also indicated
that GSPs cause, in a dose-dependent manner, HNSCC cells to
release cytochrome c from mitochondria. Subsequently, the
cytochrome c enters the cytoplasm, activating or cleaving
caspase-3 and poly (ADP-ribose) polymerase in the cyto-
plasm. Thus, apoptosis is induced. King et al50 found that GSP
extract can significantly inhibit, in a dose-dependent manner,
the cell line proliferation of human OSCC and reduce the
proliferation-promoting effects that human papillomavirus 6
has on OSCC cells. In conclusion, proanthocyanidins are
phytonutrients that have great potential for treating HNSCC.
2.2.3. Other PPs
Red grape skin is rich in resveratrol, and the resveratrol
content of red wine is approximately 2.0e40.0 mM.51
Resveratrol is an inducer of multiple cell death pathways
including apoptosis, autophagy, and mitotic catastrophe.52
ElAttar and Virji53 argued that the resveratrol in red wine
can effectively inhibit the growth and proliferation of oral
squamous carcinoma cells (SCC-25). Tang et al54 demon-
strated that resveratrol inhibits esophageal squamous cell
carcinoma (ESCC) EC109 and EC9706 cell growth by
inducing cell cycle arrest at the sub-G1 phase, resulting in
subsequent apoptosis. Resveratrol-induced apoptosis is
enhanced by the inhibition of autophagy. Quercetin can be
found in glycosylated form in fruits, nuts, vegetables, and red
wine. Initial digestion can be performed in the oral cavity
through b-glycosidases, and the cleavaged glycosides hydro-
lyze to the aglycones. Dietary flavonoid glucosides may thus
be hydrolyzed in the oral cavity by both bacteria and shedded
epithelial cells to deliver biologically active aglycones at the
surface of epithelial cells. The aglycones quercetin and gen-
istein both potently inhibited the proliferation of oral cancer
cells.29 Curcumin, a xanthophyl that exists in turmeric, has
antioxidant and immunomodulatory capacities and can inhibit
angiogenesis and induce apoptosis.55 Khafif et al56 found that
curcumin can effectively inhibit the occurrence of precancer-
ous lesions in normal oral epithelial cells of humans and cell
line growth of squamous cell carcinoma. Recent evidence has
revealed that curcumin is a potent autophagy inducer in human
cancer cell lines in vitro, such as oesophageal squamous and
adenocarcinoma cell lines OE21, OE33, and KYSE450 cells57
and oral squamous cell carcinoma cells YD10B.58 Both
apoptosis and autophagy are often simultaneously observed
after curcumin treatment.58,59 Eukaryotic elongation factor-2
kinase (EEF2K) is a controller of endoplasmic reticulum
(ER) stress-induced autophagy and apoptosis in cancer cells.
The integrated regulation of autophagy and apoptosis by
EEF2K controls cellular fate and modulates the efficacy of
curcumin.59 In a clinical trial conducted by Cheng et al,60 the
scholars prescribed an oral supplement of curcumin to cases
with a high risk of squamous cell carcinoma. The dose was upto 8 g/day, with no toxicity observed. The results of cell ex-
periments regarding head and neck cancer indicated that cur-
cumin can inhibit cancer cell proliferation by adjusting
caspase-3-dependent signaling and the signaling pathways of
cells such as NF-kb.61,62 Clark et al63 found that curcumin
inhibited the activity of MMP-9 in nicotine-activated cells and
the nicotine-induced migration of HNSCC. Curcumin inhibits
the adverse effects of nicotine by blocking nicotine-induced
activation of the AKT/mammalian target of rapamycin
(MTOR) pathway in HNSCC, which impedes cell migration.
In conclusion, in addition to discontinuing unhealthy habits
such as betel nut chewing, smoking, and drinking, the pre-
vention and treatment of head and neck cancer can be ach-
ieved by increasing dietary intake of vegetables and fruits,
which are rich in phytochemicals. Thus, internal antioxidant
capacity is enhanced and normal cells are protected. Addi-
tionally, phytochemicals can be used to control the progression
of tumor cell cycles, preventing canceration. When applied for
preventing and treating head and neck cancer, phytochemicals
can decrease the side effects of chemoradiotherapy and in-
crease the survival rates of patients in addition to decreasing
the recurrence rate of second primary cancer. Thus, phyto-
chemicals have great potential for relevant treatments. The
benefit of a diet rich in a wide variety of fruits and vegetables
daily is attributed to the complex mixture of phytochemicals.
It is best to use several anticancer and antioxidant agents for
synergistic prevention along all the possible pathways. The
clinical application of cancer chemoprevention is at an initial
stage, and the mechanism of phytochemicals in assisting
cancer prevention and treatment warrants further research.
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